Accès gratuit
Numéro
Med Sci (Paris)
Volume 20, Numéro 1, Janvier 2004
Page(s) 19 - 21
Section Nouvelles
DOI https://doi.org/10.1051/medsci/200420119
Publié en ligne 15 janvier 2004
  1. Pardoll D. T cells and tumors. Nature 2001; 411 : 1010–2.
  2. Rosenberg SA. Progress in human tumour immunology and immunotherapy. Nature 2001; 411 : 380–4.
  3. Blackburn EH. Telomerases. Annu Rev Biochem 1992; 61 : 113–29.
  4. Counter CM, Avilion AA, LeFeuvre CE, et al. Telomere shortening associated with chromosome instability is arrested in immortal celles which express telomerase activity. EMBO J 1992; 11 : 1921–9.
  5. Kim NW, Piatyszek MA, Prowse KR, et al. Specific association of human telomerase activity with immortal celles an cancer. Science 1994; 266 : 2011–5.
  6. Broccoli D, Young JW, de Lange T. Telomerase activity in normal an malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92 : 9082–6.
  7. Meyerson M, Counter CM, Eaton EN, et al. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor celles an during immortalization. Cell 1997; 90 : 785–95.
  8. Kim NW. Clinical implications of telomerase in cancer. Eur J Cancer 1997; 33 : 781–6.
  9. Nakamura TM, Morin GB, Chapman KB, et al. Telomerase catalytic subunit homologs from fission yeast an human. Science 1997; 277 : 955–9.
  10. Shay JW, Wright WE. Telomerase : a target for cancer therapeutics. Cancer Cell 2002; 2 : 257–65.
  11. Vonderheide RH, Hahn WC, Schultze JL, Nadler LM. The telomerase catalytic subunit is a widely expressed tumor-associated antigen recognized by cytotoxic T lymphocytes. Immunity 1999; 10 : 673–9.
  12. Minev B, Hipp J, Firat H, et al. Cytotoxic T cell immunity against telomerase reverse transcriptase in humans. Proc Natl Acad Sci USA 2000; 97 : 4796–801.
  13. Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase. Clin Cancer Res 2001; 7 : 3343–8.
  14. Vonderheide RH, Schultze JL, Anderson KS, et al. Equivalent induction of telomerase-specific cytotoxic T lymphocytes from tumor-bearing patients and healthy individuals. Cancer Res 2001; 61 : 8366–70.
  15. Nair SK, Heiser A, Boczkowski D, et al. Induction of cytotoxic T cell responses an tumor immunity against unrelated tumors using telomerase reverse transcriptase RNA transfected dendritic cells. Nat Med 2000; 6 : 1011–7.
  16. Nanda NK,Sercarz EE. Induction of anti-self-immunity to cure cancer. Cell 1995 14; 82 : 13–7.
  17. Houghton AN. Cancer antigens : immune recognition of self an altered self. J Exp Med 1994; 180 : 1–4.
  18. Vonderheide RH. Telomerase as a universel tumor-associated antigen for cancer immunotherapy. Oncogene 2002; 21 : 674–9.
  19. Hernandez J, Garcia-Pons F, Lone YC, et al. Identification of a human telomerase reverse transcriptase peptide of low affinity for HLA A2.1 that induces cytotoxic T lymphocytes and mediates lysis of tumor celles. Proc Natl Acad Sci USA 2002; 99 : 12275–80.

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.